Leonardo Fabbri
- Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failureBy Piera Boschetto, Barbara Bottazzi, Alessandro Fucili, Alfredo Potena, Licia Ballerin, Mariarita Stendardo, Simonetta Piva, Alessia Verduri, Bianca Beghé, Alberto Mantovani, Leonardo Fabbri, Roberto Ferrari and Claudio CeconiPiera Boschetto1Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyBarbara Bottazzi2Research Laboratory Immunology & Inflammation, Istituto Clinico Humanitas, IRCCS, Milano, ItalyAlessandro Fucili1Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyAlfredo Potena3Respiratory Physio-Pathology Unit, Hospital-University of Ferrara, Ferrara, ItalyLicia Ballerin3Respiratory Physio-Pathology Unit, Hospital-University of Ferrara, Ferrara, ItalyMariarita Stendardo1Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalySimonetta Piva1Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyAlessia Verduri4Department of Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyBianca Beghé4Department of Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyAlberto MantovaniLeonardo Fabbri4Department of Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyRoberto Ferrari1Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyClaudio Ceconi1Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy
- Effects of roflumilast in highly symptomatic COPD patientsBy Leonardo Fabbri, Udo-Michael Goehring, Manja Brose and Klaus RabeLeonardo Fabbri1Department of Respiratory Medicine, University of Modena & Reggio Emilia, Modena, ItalyUdo-Michael Goehring1Department of Respiratory Medicine, University of Modena & Reggio Emilia, Modena, ItalyManja Brose1Department of Respiratory Medicine, University of Modena & Reggio Emilia, Modena, ItalyKlaus Rabe1Department of Respiratory Medicine, University of Modena & Reggio Emilia, Modena, Italy
- Platelets count in chronic obstructive pulmonary diseaseBy Ernesto Crisafulli, Marco Marietta, Elena Venturelli, Mihai Roca, Bianca Beghè, Monica Bortolotti, Alessia Verduri, Mario Malerba, Michele Malagola, Leonardo Fabbri and Enrico CliniErnesto Crisafulli1Pulmonary Rehabilitation, Ospedale Villa Pineta, Pavullo - Modena, ItalyMarco Marietta2DAI Oncology, Haematology and Pneumology, University of Modena, ItalyElena Venturelli1Pulmonary Rehabilitation, Ospedale Villa Pineta, Pavullo - Modena, Italy2DAI Oncology, Haematology and Pneumology, University of Modena, ItalyMihai Roca3Dpt. of Pneumology, University of Iasi, RomaniaBianca Beghè2DAI Oncology, Haematology and Pneumology, University of Modena, ItalyMonica Bortolotti2DAI Oncology, Haematology and Pneumology, University of Modena, ItalyAlessia Verduri2DAI Oncology, Haematology and Pneumology, University of Modena, ItalyMario Malerba4Dpt. Internal Medicine, University of Brescia, ItalyMichele Malagola5Dpt. Haematology, University of Brescia, ItalyLeonardo Fabbri2DAI Oncology, Haematology and Pneumology, University of Modena, ItalyEnrico Clini1Pulmonary Rehabilitation, Ospedale Villa Pineta, Pavullo - Modena, Italy2DAI Oncology, Haematology and Pneumology, University of Modena, Italy
- Pooled analyses of QTcF across six phase 2b studies with glycopyrrolate-formoterol fumarate (GFF) MDI (PT003), its components and active comparatorsBy Leonardo Fabbri, Roberto Rodriguez-Roisin, Chadwick Orevillo, Carlos Fernandez, Patrick Darken, Earl St. Rose, Christine Kollar and Colin ReisnerLeonardo Fabbri1Department of Medical and Surgical Specialties, Section of Respiratory Diseases, University of Modena and Reggio Emilia, Modena, ItalyRoberto Rodriguez-Roisin2Servei De Pneumologia (ICT), Hospital Clínic, Universitat De Barcelona, Barcelona, SpainChadwick Orevillo3Clinical Development, Pearl Therapeutics, Inc., Redwood City, CA, United StatesCarlos Fernandez3Clinical Development, Pearl Therapeutics, Inc., Redwood City, CA, United StatesPatrick Darken3Clinical Development, Pearl Therapeutics, Inc., Redwood City, CA, United StatesEarl St. Rose3Clinical Development, Pearl Therapeutics, Inc., Redwood City, CA, United StatesChristine Kollar4Biostatistics, Everest Clinical Research, Inc, Little Falls, NJ, United StatesColin Reisner3Clinical Development, Pearl Therapeutics, Inc., Redwood City, CA, United States
- Cardiac events among patients with CV comorbidities: Pooled analysis of COPD trials comparing tiotropium with salmeterolBy Kai-Michael Beeh, Klaus Rabe, Thomas Glaab, Diego Wyszynski, Inge Leimer, Norbert Metzdorf, Claus Vogelmeier and Leonardo FabbriKai-Michael Beeh1Department of Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, Wiesbaden, GermanyKlaus Rabe2Pneumologie, Krankenhaus Großhansdorf, Großhansdorf, GermanyThomas Glaab3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyDiego Wyszynski4Pharmaco Vigilance, Boehringer Ingelheim Limited, Bracknell, United KingdomInge Leimer3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyNorbert Metzdorf3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyClaus Vogelmeier5Internal Medicine, Hospital of the University of Marburg, Philipps-Universtat Marburg, Marburg, GermanyLeonardo Fabbri6Department of Medical and Surgical Specialties, University of Modena & Reggio Emilia, Modena, Italy
- Comparison of cardiovascular safety in a pooled analysis of COPD trials comparing tiotropium with salmeterolBy Claus Vogelmeier, Leonardo Fabbri, Thomas Glaab, Diego Wyszynski, Inge Leimer, Norbert Metzdorf, Kai-Michael Beeh and Klaus RabeClaus Vogelmeier1Department of Internal Medicine, Division for Pulmonary Disease, Hospital of the University of Marburg, Philipps-Universtat Marburg, Marburg, GermanyLeonardo Fabbri2Department of Medical and Surgical Specialties, University of Modena & Reggio Emilia, Modena, ItalyThomas Glaab3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyDiego Wyszynski4Pharmaco Vigilance, Boehringer Ingelheim Limited, Bracknell, United KingdomInge Leimer3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyNorbert Metzdorf3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyKai-Michael Beeh5Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, Wiesbaden, GermanyKlaus Rabe6Pneumologie, Krankenhaus Großhansdorf, Großhansdorf, Germany
- Frequently asked questions (FAQs) about the GOLD 2011 assessment proposal of COPDBy Alvar Agusti, Suzanne Hurd, Paul Jones, Leonardo Fabbri, Fernando Martinez, Claus Vogelmeier, Jørgen Vestbo and Robert Rodriguez-RoisinArticle | Published in 2013 in European Respiratory JournalAlvar Agusti*Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona#FISIB, CIBER Enfermedades Respiratorias (CIBERES), Mallorca, SpainSuzanne Hurd¶Global Initiative for Chronic Obstructive Lung Disease, Vancouver, WashingtonPaul Jones+St George's Hospital Medical School, London, United KingdomLeonardo Fabbri§University of Modena and Reggio Emilia, Modena, ItalyFernando MartinezfUniversity of Michigan School of Medicine, Ann Arbor, MichiganClaus Vogelmeier**Dept of Respiratory Medicine, University of Marburg, Marburg GermanyJørgen Vestbo##Manchester Academic Health Sciences Centre, South Manchester University Hospital NHS Foundation Trust, Manchester, UK (and) Odense University Hospital and University of Southern Denmark, Odense, DenmarkRobert Rodriguez-Roisin*Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona
- COPD in the 21st CenturyEdited by Jadwiga A. Wedzicha, James P. Allinson and Peter M.A. CalverleyBook | Published in 2024DOI: 10.1183/2312508X.erm10324ISBN (electronic): 978-1-84984-176-4Jadwiga A. WedzichaJames P. Allinson
- TABLE 2By Maarten van den Berge, Bianca Beghé, Lies Lahousse, Sami O. Simons, Lowie Vanfleteren and Leonardo FabbriBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Maarten van den BergeBianca BeghéLies LahousseSami O. SimonsLowie Vanfleteren - TABLE 1By Maarten van den Berge, Bianca Beghé, Lies Lahousse, Sami O. Simons, Lowie Vanfleteren and Leonardo FabbriBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Maarten van den BergeBianca BeghéLies LahousseSami O. SimonsLowie Vanfleteren - TABLE 3By Maarten van den Berge, Bianca Beghé, Lies Lahousse, Sami O. Simons, Lowie Vanfleteren and Leonardo FabbriBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Maarten van den BergeBianca BeghéLies LahousseSami O. SimonsLowie Vanfleteren - FIGURE 1By Maarten van den Berge, Bianca Beghé, Lies Lahousse, Sami O. Simons, Lowie Vanfleteren and Leonardo FabbriBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Maarten van den BergeBianca BeghéLies LahousseSami O. SimonsLowie Vanfleteren - FIGURE 2By Maarten van den Berge, Bianca Beghé, Lies Lahousse, Sami O. Simons, Lowie Vanfleteren and Leonardo FabbriBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Maarten van den BergeBianca BeghéLies LahousseSami O. SimonsLowie Vanfleteren - FIGURE 3By Maarten van den Berge, Bianca Beghé, Lies Lahousse, Sami O. Simons, Lowie Vanfleteren and Leonardo FabbriBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Maarten van den BergeBianca BeghéLies LahousseSami O. SimonsLowie Vanfleteren - FIGURE 4By Maarten van den Berge, Bianca Beghé, Lies Lahousse, Sami O. Simons, Lowie Vanfleteren and Leonardo FabbriBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
Maarten van den BergeBianca BeghéLies LahousseSami O. SimonsLowie Vanfleteren
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.